Trials / Unknown
UnknownNCT05284825
A Phase II Trial of Intermediate Radiation Dose For Lymphoma
A Phase II Trial of Intermediate Radiation Dose For Low Grade Follicular Lymphoma
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 27 (estimated)
- Sponsor
- Sunnybrook Health Sciences Centre · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine the optimal radiation dose fractionation regimen for low grade follicular lymphoma. It is hypothesized that the complete response rate with the use of 12 Gy in 6 daily fractions is 80% (10% total width of the confidence interval) at 3 months. This phase II study will evaluate whether an intermediate dose for follicular lymphoma is associated with excellent response rates while minimizing acute and late toxicity.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | 12 Gy in 6 daily fractions | 12 Gy in 6 daily fractions |
Timeline
- Start date
- 2022-02-28
- Primary completion
- 2025-01-01
- Completion
- 2025-01-01
- First posted
- 2022-03-17
- Last updated
- 2024-02-15
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT05284825. Inclusion in this directory is not an endorsement.